Nahdi Medical - Public Comps and Valuation Multiples

Nahdi Medical Overview

About Nahdi Medical

Nahdi Medical Co is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It has two operating segments Front Shop and Pharma.

Founded

1986

HQ

Employees

n/a

Website

nahdi.sa

Sectors

Pharmacies

Financials

LTM Revenue $2.7B

LTM EBITDA $453M

EV

$4.1B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Nahdi Medical Financials

As of August 2025, Nahdi Medical reported last 12-month revenue of $2.7B and EBITDA of $453M.

In the same period, Nahdi Medical generated $1.0B in LTM gross profit and $227M in net income.

See Nahdi Medical valuation multiples based on analyst estimates

Nahdi Medical P&L

In the most recent fiscal year, Nahdi Medical reported revenue of $2.5B and EBITDA of $430M.

Nahdi Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Nahdi Medical valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$2.7B	XXX	$2.5B	XXX	XXX	XXX
Gross Profit	$1.0B	XXX	$943M	XXX	XXX	XXX
Gross Margin	38%	XXX	37%	XXX	XXX	XXX
EBITDA	$453M	XXX	$430M	XXX	XXX	XXX
EBITDA Margin	17%	XXX	17%	XXX	XXX	XXX
EBIT	$250M	XXX	$231M	XXX	XXX	XXX
EBIT Margin	9%	XXX	9%	XXX	XXX	XXX
Net Profit	$227M	XXX	$219M	XXX	XXX	XXX
Net Margin	8%	XXX	9%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Nahdi Medical including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $2.7B. EBITDA for the last twelve months was $453M. In the most recent fiscal year, Nahdi Medical achieved $2.5B in revenue and $430M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$2.7B	Analyst estimates available to subscribers	$2.5B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$1.0B	Analyst estimates available to subscribers	$943M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	37.8% gross margin	Analyst estimates available to subscribers	37.4% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$453M	Analyst estimates available to subscribers	$430M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	17.0% EBITDA margin	Analyst estimates available to subscribers	17.1% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$250M	Analyst estimates available to subscribers	$231M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	9.4% EBIT margin	Analyst estimates available to subscribers	9.2% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$227M	Analyst estimates available to subscribers	$219M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	8.5% net profit margin	Analyst estimates available to subscribers	8.7% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Nahdi Medical

This financial data table provides comprehensive performance metrics for Nahdi Medical, a company based in Saudi Arabia. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Nahdi Medical generated $2.7B in revenue over the last twelve months.
The company achieved $453M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $1.0B.
Net income over the last twelve months reached $227M.

Fiscal Year Performance

In the most recent fiscal year, Nahdi Medical reported $2.5B in total revenue.
Fiscal year EBITDA was $430M.
The company maintained a gross profit margin of 37.4% in the most recent fiscal year.
EBITDA margin for the fiscal year was 17.1%.
Net profit margin reached 8.7% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Nahdi Medical. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Nahdi Medical Stock Performance

Nahdi Medical has current market cap of SAR 14.5B (or $3.9B), and EV of SAR 15.5B (or $4.1B).

Market Cap Evolution

Nahdi Medical Stock Data

As of September 12, 2025, Nahdi Medical's stock price is SAR 112 (or $30).

See Nahdi Medical trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$4.1B	$3.9B	XXX	XXX	XXX	XXX	$1.73

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Nahdi Medical Valuation Multiples

Nahdi Medical's trades at 1.6x EV/Revenue multiple, and 9.6x EV/EBITDA.

See valuation multiples for Nahdi Medical and 15K+ public comps

Nahdi Medical Financial Valuation Multiples

As of September 12, 2025, Nahdi Medical has market cap of $3.9B and EV of $4.1B.

Equity research analysts estimate Nahdi Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Nahdi Medical has a P/E ratio of 17.1x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$3.9B	XXX	$3.9B	XXX	XXX	XXX
EV (current)	$4.1B	XXX	$4.1B	XXX	XXX	XXX
EV/Revenue	1.5x	XXX	1.6x	XXX	XXX	XXX
EV/EBITDA	9.1x	XXX	9.6x	XXX	XXX	XXX
EV/EBIT	16.5x	XXX	17.9x	XXX	XXX	XXX
EV/Gross Profit	4.1x	XXX	n/a	XXX	XXX	XXX
P/E	17.1x	XXX	17.7x	XXX	XXX	XXX
EV/FCF	20.4x	XXX	14.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Nahdi Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Nahdi Medical Margins & Growth Rates

Nahdi Medical's last 12 month revenue growth is 8%

Nahdi Medical's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Nahdi Medical's rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Nahdi Medical's rule of X is 38% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Nahdi Medical and other 15K+ public comps

Nahdi Medical Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	8%	XXX	8%	XXX	XXX	XXX
EBITDA Margin	17%	XXX	17%	XXX	XXX	XXX
EBITDA Growth	10%	XXX	4%	XXX	XXX	XXX
Rule of 40	27%	XXX	25%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	38%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	4%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	28%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial